Dr. Lauren Anne Eberly, MD

Dr. Eberly practices at Hospital of the University of Pennsylvania - Cedar Avenue in Philadelphia, Pennsylvania.

Dr. Eberly's NPI, 1487035754, was assigned on June 12, 2015. Dr. Eberly graduated from University of New Mexico School of Medicine in 2015. Dr. Eberly holds Pennsylvania license MD472959.

Dr. Eberly's primary practice is Hospital of the University of Pennsylvania - Cedar Avenue, at 501 S 54th St, Philadelphia, PA 19143 in Philadelphia County. The practice phone is (215) 762-0888.

Dr. Eberly's primary practice is Hospital of the University of Pennsylvania - Cedar Avenue in Philadelphia, Pennsylvania. Dr. Eberly is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Eberly to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eberly practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Eberly's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Eberly is licensed in Pennsylvania.

CMS data shows 344 Medicare services from Dr. Eberly across 8 procedure codes in 2024, for 204 Medicare patients. Medicare paid $10,444 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 204 Medicare patients who saw Dr. Eberly in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eberly's median patient age at 53, with 53% women.

In 2024, Dr. Eberly wrote 276 Medicare Part D claims for 40 patients. 64% of them were for generic drugs. CMS names the drug for 190 of them, across 11 drugs with 11 or more claims each, at $63,169 in total drug cost. In 2023, CMS named 230 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Eberly for performance year 2024, reported as part of a group. Dr. Eberly accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 61 papers to Dr. Eberly, published from 2014 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Cardiovascular Diseases, Medicare and Black or African American. Dr. Eberly has published most often in Circ Cardiovasc Qual Outcomes. Dr. Eberly's most frequent co-authors are Ashwin Senthil Nathan, MD, Howard M. Julien and Alexander C. Fanaroff, MD, MHS.

CMS Open Payments shows 22 general payments to Dr. Eberly from 13 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 88% of the total. Boehringer Ingelheim USA, Inc. paid the most, $2,610.

Dr. Eberly graduated from University of New Mexico School of Medicine in 2015.